
|Articles|May 18, 2011
Today's Daily Dose: Piroxicam
Learn about the potential anticancer effects of piroxicam.
Advertisement
Untitled Document
“The potential anticancer effects of piroxicam in cats with transitional cell carcinoma have not been thoroughly described, but, anecdoctally, piroxicam appears to be well-tolerated at a dosage of 0.3 mg/kg by mouth two or three times a week. Using this dosing scheme in cats with transitional cell carcinoma should be safe based on prior pharmacokinetic studies of oral piroxicam conducted in healthy cats; however, its anticancer effectiveness remains poorly characterized in cancer-bearing cats.”
Advertisement
-Timothy M. Fan, DVM, PhD, DACVIM (internal medicine and oncology)
From
Advertisement
Latest CME
Advertisement
Advertisement
Trending on dvm360
1
FDA issues emergency use authorization for ivermectin solution to prevent screwworm in horses
2
Every 30 extra minutes under anesthesia raises complication risk in brachycephalic patients, underscoring the importance of peri-anesthetic management
3
From the CVO: I’m off the clock
4
Paws and profits: VetEvolve names first chief veterinary officer, NVA appoints two board members, and more updates
5









